The Vascular Company's cash balance at December 31, 20X1, was $150,000. The following information was reported on the company's statement of cash flows for 20X2: Net Income $ 342,000 Depreciation 91,000 Increase in Accounts Receivable 62,000 Increase in Inventory 137,000 Decrease in Accounts Payable 43,000 Dividends Paid to Shareholders 35,000 Proceeds from Sale of Common Stock 400,000 Repayment of Bonds Payable 240,000 Proceeds of Sale of Equipment with Book Value of $84,000 61,000 Purchase of Land and Building 416,000 The Vascular Company's Statement of Cash Flows would report Cash Flows from Investing Activities totaling